Ocugen, Inc. announced that effective from August 14, 2023, Quan Vu is no longer serving as the Chief Business Officer, and as principal financial officer and principal accounting officer, of Ocugen, Inc. The separation from employment is being treated as a severance qualifying event under Mr. Vu?s employment agreement. On August 15, 2023, the Company?s Board of Directors appointed Shankar Musunuri, Ph.D., MBA, as the company?s chairman, as the interim principal financial officer, effective immediately, in light of Mr. Vu?s departure.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.55 USD | -3.12% | -8.82% | +169.57% |
May. 31 | Sector Update: Health Care Stocks Advance Friday Afternoon | MT |
May. 31 | Ocugen Gets Recommendation For Dose Escalation in Eye Disease Trial; Shares Climb | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+169.57% | 399M | |
+49.41% | 56.95B | |
+40.06% | 40.26B | |
-6.72% | 39.32B | |
-5.96% | 28.37B | |
+12.99% | 26.45B | |
-19.82% | 19.41B | |
+32.35% | 12.54B | |
-0.08% | 12.15B | |
+25.18% | 12.21B |
- Stock Market
- Equities
- OCGN Stock
- News Ocugen, Inc.
- Ocugen, Inc. Announces Executive Changes